New Delhi: India’s apex pharma export body has sent an “SOS” message to the Narendra Modi government seeking an intervention as drug makers are facing “acute disruption” in manufacturing of pharmaceutical products due to non-clearance of products imported from China across the country, ThePrint has learnt.
In a letter to the Department of Pharmaceuticals (DoP) secretary, which ThePrint has accessed, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said pharma products including key starting materials (KSMs), intermediaries and active pharmaceutical ingredients (APIs) are stuck at ports and airports, especially in Maharashtra and Delhi.
Even Covid-19 related medical devices and diagnostics are stuck, the body stated.
A DoP official who didn’t wish to be identified said these goods are imported from China. However, due to the ongoing border standoff in Ladakh, officers at ports and airports are inspecting all consignments instead of random checks leading to delays, the official said, adding that consignments from the government-run Hindustan Latex Limited’s (HLL) have also been held at customs. “HLL had placed orders to import masks and protective goggles,” the official said.
“We have been inundated with distress calls from a lot of our member companies that there has been an acute disruption in manufacturing of pharmaceutical products over the last three days,” said the letter dated 27 June. It has also been marked to officials in other ministries, including external affairs and health and family welfare.
Set up under the provisions of Foreign Trade Policy in 2004, Pharmexcil functions under the Ministry of Commerce and Industry and works for promoting pharmaceutical exports from India.
Critical Covid-related orders also being held
In the letter, written by Pharmexcil director Udaya Bhaskar, the body said diagnostic devices and medical equipment needed for ensuring Covid care were also being held up at Customs.
We are deeply grateful to our readers & viewers for their time, trust and subscriptions.
Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrint’s future.
“Very critical KSM’s, Intermediates and API’s are not being cleared for the reasons not known the industry at all. Even in the case of medical devices and critical diagnostic devices such as infrared thermometers and pulse oximeters which are specifically aimed at Covid diagnosis are also held up at Delhi Port,” said the letter.
Commonly used diagnostics such as glucometers and strips are also stuck.
To “illustrate the grave situation”, the letter said “we urgently appeal to you to kindly intervene in the matter on save our ship (SOS) and kindly instruct that clearances from customs are permitted”.
“All these materials which are genuine in nature should be cleared and dispatched to ensure there is no disruption of manufacturing at all under any circumstances,” it said.
‘Self sufficiency will take time’
Pharmexcil warned of consequences for the industry if the clearances are not expedited.
“…man made disruptions as stated above as have created tremendous difficulties for the industry and we sincerely fear that if the same are not expedited on top priority in terms of clearances, whatever great work has been done in the past through your good offices to help the industry to maintain the current 90-100% production and supply chain may get completed diluted,” it said.
While talking about the “good work” done by government departments in the past, the letter highlighted that the “self sufficiency” or “Atma Nirbharta” principle will take its own time in a “phased and considered manner”.
This was a reference to the Modi government’s call for self-reliance amid the Covid crisis.
“During current distressed and challenging times of global Covid-19 pandemic, pharmaceutical industry has risen to meet with the challenge,” it said, counting the 27 per cent export growth in May 2020 from a year ago as it surpassed $2 billion.
“India has been acknowledged as ‘Pharmacy to the World’ as well as a very humane, generous country supplying critical Covid related medicines to 100+ countries,” it added.
News media is in a crisis & only you can fix it
You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.
You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the media’s economics is broken. But a big one is that good people are not yet paying enough for good journalism.
We have a newsroom filled with talented young reporters. We also have the country’s most robust editing and fact-checking team, finest news photographers and video professionals. We are building India’s most ambitious and energetic news platform. And we aren’t even three yet.
At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.
This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.
If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrint’s future. It will take just a few seconds of your time.